Hanley Jr. Michael Conick 4
4 · Aeglea BioTherapeutics, Inc. · Filed Jun 10, 2022
Insider Transaction Report
Form 4
Hanley Jr. Michael Conick
Chief Commercial Officer
Transactions
- Purchase
Common Stock
2022-06-08$0.71/sh+28,200$20,022→ 36,200 total
Footnotes (1)
- [F1]Includes 8,000 shares of common stock acquired by the Reporting Person pursuant to the Issuer's employee stock purchase plan.